|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Other current assets | ||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Payable offering costs | ||||||||||||||||||
| Deferred fundraising receipts | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Employee compensation and benefits | ||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||
| SHAREHOLDERS' EQUITY, see Note 4 | ||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
Loading...
